P09.2 – Abnormal findings on neonatal screening for congenital endocrine disease

ICD-10-CM 2027 diagnosis code · Abnormal findings on neonatal screening (P09)

Billable code

ICD-10-CM code P09.2
Code
P09.2 (claims format: P092)
Description
Abnormal findings on neonatal screening for congenital endocrine disease
Short description
Abnormal findings on neonatal screen for congen endo disease
Billable
Yes – valid for HIPAA-covered transactions
Valid for
Dates of service October 1, 2026 – September 30, 2027 (FY2027)
Chapter
16. Certain conditions originating in the perinatal period (P00-P96)
Block
P09 Abnormal findings on neonatal screening (P09)
Parent codes
P09

Notes for P09.2

Applicable to:
  • Abnormal findings on neonatal screening for congenital adrenal hyperplasia
  • Abnormal findings on neonatal screening for hypothyroidism screen

Notes inherited from parent codes

Instructional notes at a category or block level apply to every code below it.

P09 – Abnormal findings on neonatal screening

Includes:
  • Abnormal findings on state mandated newborn screens
  • Failed newborn screening
Excludes2 (not included here):
  • nonspecific serologic evidence of human immunodeficiency virus [HIV] (R75)

Index terms for P09.2

Entries in the ICD-10-CM alphabetic index that lead to this code:

Related codes in P09

Frequently asked questions

What is ICD-10 code P09.2?

P09.2 is the ICD-10-CM code for abnormal findings on neonatal screening for congenital endocrine disease, in the block P09 (Abnormal findings on neonatal screening (P09)).

Is P09.2 a billable code?

Yes. P09.2 is a billable/specific code that can be used to indicate a diagnosis for reimbursement purposes.

What category does P09.2 belong to?

It belongs to category P09 – Abnormal findings on neonatal screening.

Source: CDC/NCHS ICD-10-CM FY2027 code files, tabular list and index. Reference only – code assignment must follow the official ICD-10-CM guidelines and documentation in the medical record.